Market News & Trends
TNF Inhibitors Lay Groundwork for Next-Generation of Disease-Modifying Anti-Rheumatic Drugs
The challenges inherent in the pharmacological management of rheumatic diseases have stoked huge demand for drug classes with excellent safety and efficacy profiles. While tumor…
Curis Announces Several Major Announcements
Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group, exclusive worldwide rights for the development and commercialization of GDC-0917,…
Governor Jindal, AgraTech International Announce New Chitosan Facility
Governor Bobby Jindal and AgraTech International Inc. Chairman Richard DeMarco recently announced the company will renovate a former Opelousas bottling facility, creating 50 new direct…
Hovione & Solvias Announce Drug Solubility Collaboration
Hovione and Solvias recently announced the establishment of a collaboration focused on the development and GMP supply of pharmaceutical co-crystals. This strengthens Hovione's expertise and…
New Technology for Producing Thermostable Vaccines
Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) recently announced the development of a new technology for the production of thermostable…
Selecta Biosciences & Sanofi Sign Global Collaboration
Selecta Biosciences, Inc. recently announced it has entered into a strategic global collaboration with Sanofi to discover highly targeted, antigen-specific immunotherapies for life-threatening allergies. Under…
Tekmira Acquires Worldwide License to Novel RNAi Technology
Tekmira Pharmaceuticals Corporation recently announced it has obtained a worldwide, non-exclusive license to a novel RNAi payload technology called Unlocked Nucleobase Analog (UNA) from Marina…
12/5/2012
Curis Announces Several Major Announcements Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group, exclusive worldwide rights for the…
11/28/2012
CoreRx & ViroPro Announce Agreement CoreRx, Inc. and Viropro, Inc. recently announced the two companies have entered into a Reciprocal Referral Agreement. The Agreement will…
BASF Plans to Acquire Pronova BioPharma
BASF recently announced it plans to acquire Pronova BioPharma ASA, Lysaker, Norway, a pioneer in the field of research, development, and manufacturing of omega-3 fatty…
CoreRx & ViroPro Announce Agreement
CoreRx, Inc. and Viropro, Inc. recently announced the two companies have entered into a Reciprocal Referral Agreement. The Agreement will benefit both companies' existing and…
Genzyme Corporation Announces Drug Approval
Genzyme, a Sanofi company, recently announced that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO (teriflunomide) 14 mg as a new once-daily, oral treatment…
MethylGene Closes Substantial Private Placement
MethylGene Inc. recently announced it has completed its previously announced private placement of 179,690,970 units at a subscription price per unit of Cdn.$0.145 (the Subscription…
Teva to Focus on Smaller M&A
Teva Pharmaceutical Industries Ltd. is shifting away from the multi-billion dollar acquisitions that have defined its growth for the past decade, indicating acquisitions don't have…
XOMA Corporation Seeks to Sublicense Drug
XOMA Corporation recently announced the 837-patient Phase III PATH trial (Perindopril Amlodipine for the Treatment of Hypertension) has demonstrated the fixed-dose combination (FDC) of perindopril…
Innovative Drugs to Transform Alzheimer's Disease Medication Market
The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease (AD) by 2015 is likely to cause a steep decline in the growth…
Intarcia Therapeutics Secures Landmark $210-Million Financing
Intarcia Therapeutics, Inc. recently announced the simultaneous completion of two financings with total proceeds of $210 million, the largest sum to be raised by a…
Jubilant HollisterStier Secures Significant Contracts
Jubilant HollisterStier, a subsidiary of Jubilant Life Sciences, recently announced its Contract Manufacturing & Services division has recently secured over $100 million in contracts with…
Nanoparticle Technology Facilitates Cancer Metastasis Research
NanoSight, leading manufacturers of unique nanoparticle characterization technology, recently reported on the breakthrough cancer metastasis research of Dr. Hector Peinado Selgas and Dr. David Lyden's…
11/21/2012
Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease (AD) by 2015 is likely…
